Brief outlook about Zahraa Zahraa Al Zahraa is

Brief outlook about Zahraa

Zahraa � Al Zahraa is a fast growing privately owned Egyptian company; established in 1994 with its main office in Cairo- Egypt. � It was founded by a group of professionals, who spent a great deal of time learning and working in various pharmaceutical companies; and had a good professional experience in that field. � We are a fast growing Co. focusing on Importing, providing, and marketing medical oncology drugs and otherapeutic specialties of significant unmet medical drugs.

� We started our activity as an agent foreign suppliers in the field of active pharmaceutical ingredients”API”. � We promote & distribute (API’s) to the Pharma industry (public & private sector). � In 2005, due to the growth and expanding fast of al-Zahraa& the market as well , Al-Zahraa diversifies to two main Activities: - 1. a. Continuing our business in API’ 2. b. Our new Activity in importing finished drugs, in the field of oncology line.

� On that base we have been granting the representation of reputable international companies from Switzerland &Germany � Representing them as an exclusive Sole Agent& distributer in Egypt for their generic

Our Vision � To be amongst the top providers of oncology specialty products in Egypt, Middle and North Africa. � Al Zahraa defines common values, goals and strategies for a better quality of life to human kind. � To occupy a leading market position in each of these specialty areas. � To maximize our profitability over the long term while our core of business continues to thrive and grow, our eyes is always on opportunities. � Al-Zahraa’s future challenges are truly existing, new products launches, market expansion, and competition among Multinationals.

Our Mission � “We are building a strong platform to serve our medical market and distinctively and competitively meet the ever changing demand in health care. � Focusing on our unique portfolio of quality medicines at well designed and affordable prices. � Through our activities we touch a great number of people’s lives and we are acutely conscious of our responsibility to patients and society in general.

� We are small; but very committed to growth; integrity and the values to our customers & our society. � We are dedicated to providing high medical value to physicians; patients and medical care organizations. The clue is in our name” You have seen the word “Zahraa” but you never thought what this name in the context of our mission is. �

Business Model � Our Unique business that we are working on is a niche market for only oncology products. � What we are best compared to our competitors; that our drugs is a very high quality with a better price.

� We are working on an incidence disease that is increasing yearly by 20% in Egypt, each year we have 100, 000 new cancer patients. � We can be best on focusing on this target market, through our social responsibility through our society � We need to shore up the weaknesses, capitalize on the opportunities and recognize threats.

ONCOLOGY PORTFOLIO

ANASTRAZOLE

� ANTI HORMONAL DRUG : - Form Strength Origin Country Company name Pack price l. E Tablet box(30 tab) 1 mg Germany Haemato Pharm 310 L. E

GEMCITABINE HCL

� Anti metabolites: “ Gemci-Haemato“ Form Strength Origin Country Company Name pack price L. E Vial 1 g Germany Haemato Pharm 465 L. E Vial 200 mg Germany Haemato Pharm 129 L. E

PACLITAXEL STRAGEN 6 MG/ML

� Anti mitotic: - Form Strength Origin Country Company Name pack price L. E Vial 30 mg/5 ml Switzerland Stragen Pharma S. A 195 L. E Vial 100 mg/16. 7 ml Switzerland Stragen Pharma S. A 950 L. E Vial 150 g/25 ml Switzerland Stragen Pharma S. A 1600 L. E Vial 300 mg/50 ml Switzerland Stragen Pharma S. A 3000 L. E

CYPROTERONE ACETATE

�Anti androgen: - Form Tablet Box(20 tab) Strength Origin Country Company Name pack price L. E 50 mg United Kingdom Stragen UK Ltd. 80 L. E